Walker, Rosie M. https://orcid.org/0000-0002-1060-4479
Vaher, Kadi
Bermingham, Mairead L.
Morris, Stewart W.
Bretherick, Andrew D.
Zeng, Yanni
Rawlik, Konrad
Amador, Carmen
Campbell, Archie
Haley, Chris S.
Hayward, Caroline
Porteous, David J.
McIntosh, Andrew M.
Marioni, Riccardo E.
Evans, Kathryn L.
Funding for this research was provided by:
Wellcome Trust (104036/Z/14/Z, 108890/Z/15/Z, 204979/Z/16/Z, 104036/Z/14/Z, 10436/Z/14/Z)
Medical Research Council (MC_PC_17209)
Chief Scientist Office, Scottish Government Health and Social Care Directorate (CZD/16/6)
Brain and Behavior Research Foundation (27404)
Alzheimer’s Research UK (ARUK-PG2017B-10)
Article History
Received: 19 March 2020
Accepted: 12 November 2020
First Online: 4 January 2021
Ethics approval and consent to participate
: This study is part of GS:SFHS, which obtained ethical approval from the NHS Tayside Committee on Medical Research Ethics, on behalf of the National Health Service (reference: 05/S1401/89). All participants provided broad and enduring written informed consent for biomedical research. GS:SFHS has Research Tissue Bank Status (reference: 15/ES/0040), providing generic ethical approval for a wide range of uses within medical research. All experimental methods were in accordance with the Helsinki declaration.
: Not applicable
: AMM has received grant support from Pfizer, Eli Lilly, Janssen and The Sackler Trust. These sources are not connected to the current investigation. AMM has also received speaker fees from Janssen and Illumina. The remaining authors declare that they have no competing interests. The funding bodies did not play any role in the design of the study, the collection, analysis or interpretation of the data or in the writing of the manuscript.